Trial Details
RECRUITINGBasic Information
| Clinical ID | c679 |
|---|---|
| Identifier | NCT06619990 |
| Trial Title | Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | BIOLOGICAL: XmAb942|DRUG: Placebo |
Participant Information
| Sponsor | GALE Therapeutics Inc. |
|---|---|
| City | Joondalup |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2024-10-10 |
|---|---|
| Primary Completion Date | 2025-10-26 |
| Completion Date | 2025-10-27 |